Screening of candidate substrates and coupling ions of transporters by thermostability shift assays

  1. Homa Majd
  2. Martin S King
  3. Shane M Palmer
  4. Anthony C Smith
  5. Liam DH Elbourne
  6. Ian T Paulsen
  7. David Sharples
  8. Peter JF Henderson
  9. Edmund RS Kunji  Is a corresponding author
  1. University of Cambridge, United Kingdom
  2. Macquarie University, Australia
  3. University of Leeds, United Kingdom

Abstract

Substrates of most transport proteins have not been identified, limiting our understanding of their role in physiology and disease. Traditional identification methods use transport assays with radioactive compounds, but they are technically challenging and many compounds are unavailable in radioactive form or are prohibitively expensive, precluding large-scale trials. Here, we present a high-throughput screening method that can identify candidate substrates from libraries of unlabeled compounds. The assay is based on the principle that transport proteins recognize substrates through specific interactions, which lead to enhanced stabilization of the transporter population in thermostability shift assays. Representatives of three different transporter (super)families were tested, which differ in structure as well as transport and ion coupling mechanisms. In each case, the substrates were identified correctly from a large set of chemically related compounds, including stereo-isoforms. In some cases, stabilization by substrate binding was enhanced further by ions, providing testable hypotheses on energy coupling mechanisms.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided in Dryad.

The following data sets were generated

Article and author information

Author details

  1. Homa Majd

    Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Martin S King

    Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Shane M Palmer

    Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Anthony C Smith

    Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Liam DH Elbourne

    Department of Molecular Sciences, Macquarie University, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Ian T Paulsen

    Department of Molecular Sciences, Macquarie University, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  7. David Sharples

    Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Peter JF Henderson

    Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Edmund RS Kunji

    Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge, United Kingdom
    For correspondence
    ek@mrc-mbu.cam.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0610-4500

Funding

Medical Research Council (MC_UU_00015/1)

  • Homa Majd
  • Martin S King
  • Shane M Palmer
  • Anthony C Smith
  • Edmund RS Kunji

Cambridge Commonwealth, European and International Trust

  • Homa Majd

Leverhulme Trust (EM-2014 -045)

  • Peter JF Henderson

Biotechnology and Biological Sciences Research Council (MPSI BBS/B/14418)

  • David Sharples

Wellcome (JIF 062164/Z/00/Z)

  • David Sharples

University of Leeds

  • David Sharples

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2018, Majd et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,117
    views
  • 635
    downloads
  • 52
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Homa Majd
  2. Martin S King
  3. Shane M Palmer
  4. Anthony C Smith
  5. Liam DH Elbourne
  6. Ian T Paulsen
  7. David Sharples
  8. Peter JF Henderson
  9. Edmund RS Kunji
(2018)
Screening of candidate substrates and coupling ions of transporters by thermostability shift assays
eLife 7:e38821.
https://doi.org/10.7554/eLife.38821

Share this article

https://doi.org/10.7554/eLife.38821

Further reading

    1. Neuroscience
    2. Structural Biology and Molecular Biophysics
    Yangyu Wu, Yangyang Yan ... Fred J Sigworth
    Research Article

    We present near-atomic-resolution cryoEM structures of the mammalian voltage-gated potassium channel Kv1.2 in open, C-type inactivated, toxin-blocked and sodium-bound states at 3.2 Å, 2.5 Å, 3.2 Å, and 2.9 Å. These structures, all obtained at nominally zero membrane potential in detergent micelles, reveal distinct ion-occupancy patterns in the selectivity filter. The first two structures are very similar to those reported in the related Shaker channel and the much-studied Kv1.2–2.1 chimeric channel. On the other hand, two new structures show unexpected patterns of ion occupancy. First, the toxin α-Dendrotoxin, like Charybdotoxin, is seen to attach to the negatively-charged channel outer mouth, and a lysine residue penetrates into the selectivity filter, with the terminal amine coordinated by carbonyls, partially disrupting the outermost ion-binding site. In the remainder of the filter two densities of bound ions are observed, rather than three as observed with other toxin-blocked Kv channels. Second, a structure of Kv1.2 in Na+ solution does not show collapse or destabilization of the selectivity filter, but instead shows an intact selectivity filter with ion density in each binding site. We also attempted to image the C-type inactivated Kv1.2 W366F channel in Na+ solution, but the protein conformation was seen to be highly variable and only a low-resolution structure could be obtained. These findings present new insights into the stability of the selectivity filter and the mechanism of toxin block of this intensively studied, voltage-gated potassium channel.

    1. Structural Biology and Molecular Biophysics
    Kazi A Hossain, Lukasz Nierzwicki ... Giulia Palermo
    Research Article

    xCas9 is an evolved variant of the CRISPR-Cas9 genome editing system, engineered to improve specificity and reduce undesired off-target effects. How xCas9 expands the DNA targeting capability of Cas9 by recognising a series of alternative protospacer adjacent motif (PAM) sequences while ignoring others is unknown. Here, we elucidate the molecular mechanism underlying xCas9’s expanded PAM recognition and provide critical insights for expanding DNA targeting. We demonstrate that while wild-type Cas9 enforces stringent guanine selection through the rigidity of its interacting arginine dyad, xCas9 introduces flexibility in R1335, enabling selective recognition of specific PAM sequences. This increased flexibility confers a pronounced entropic preference, which also improves recognition of the canonical TGG PAM. Furthermore, xCas9 enhances DNA binding to alternative PAM sequences during the early evolution cycles, while favouring binding to the canonical PAM in the final evolution cycle. This dual functionality highlights how xCas9 broadens PAM recognition and underscores the importance of fine-tuning the flexibility of the PAM-interacting cleft as a key strategy for expanding the DNA targeting potential of CRISPR-Cas systems. These findings deepen our understanding of DNA recognition in xCas9 and may apply to other CRISPR-Cas systems with similar PAM recognition requirements.